# Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis

> **NCT06376968** · NA · RECRUITING · sponsor: **B.Braun Avitum AG** · enrollment: 56 (estimated)

## Conditions studied

- Renal Dialysis

## Interventions

- **DEVICE:** BioLogic Fusion

## Key facts

- **NCT ID:** NCT06376968
- **Lead sponsor:** B.Braun Avitum AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-22
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06376968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06376968, "Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06376968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*